Mechanisms of hepatitis B virus cccDNA formation
乙型肝炎病毒cccDNA形成机制
基本信息
- 批准号:10165502
- 负责人:
- 金额:$ 55.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAnimal ModelAntibodiesAntiviral AgentsAntiviral TherapyBiochemicalBiological AssayBiological ModelsCell Culture TechniquesCell ExtractsCell LineCell NucleusCellsCessation of lifeChronicChronic Hepatitis BCircular DNAClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesComplexDNA LigasesDNA RepairDNA lesionDNA-Directed DNA PolymeraseDataExposure toGenerationsGeneticGenomeGoalsHealthHepG2Hepatitis B VirusHepatocyteHumanIn VitroIndividualInfectionIntegration Host FactorsKineticsKnock-outLearningLesionLife Cycle StagesLiverLiver diseasesMaintenanceMalignant neoplasm of liverMediatingMethodsMolecularMonitorMusMutationNaturePan GenusPatientsPhysiologicalPlant RootsPolymeraseProcessPublic HealthRTH-1 NucleaseRecombinantsRefractoryRegimenResolutionRiskRoleSeriesSet proteinSystemTechniquesTestingTherapeutic InterventionTranscriptVaccinationViral GenomeVirionVirusVirus DiseasesVirus ReceptorsWorkYeastscytotoxicitydesignexperiencehepatoma cellhigh riskinnovationknock-downmouse modelnew therapeutic targetnoveloverexpressionpathogenic viruspreventpurgereconstitutionrepair enzymerepairedreplication factor Csmall hairpin RNA
项目摘要
Project summary
Chronic hepatitis B virus (HBV) infection results in 887,000 deaths annually. The central challenge in curing
HBV is eradication of the stable covalently closed circular DNA (cccDNA) form of the viral genome, which
depends on elusive host factors for its generation. Using a yeast extract screen, we identified five core
components of lagging strand synthesis –PCNA, the replication factor C (RFC) complex, DNA polymerase δ
(POLδ), FEN-1, and DNA ligase 1 (LIG1) – as essential for cccDNA formation. We reconstituted cccDNA
formation with purified human homologs, establishing these as a minimal set of factors necessary and
sufficient for cccDNA formation. We further demonstrated that inhibiting POLδ significantly diminishes
cccDNA formation. In this proposal, we will build on these findings to determine the precise kinetics of
cccDNA formation, delineating the role of each factor at every step of the repair process. In understanding the
dynamics of rcDNA to cccDNA repair, we can identify potential rate-limiting steps that could be novel
therapeutic targets for disrupting cccDNA formation and maintenance. Using a series of innovative techniques
in both cell culture and mouse model systems, we will be able to test our findings in physiologically relevant
platforms that will strengthen the impact of our data. Factors found to be critical for rc- to cccDNA
conversion will be disrupted in these systems by a degron-mediated approach that will allow for fine-tuned
control of expression to alleviate any potential cytotoxicity. We can then monitor the effect of each factor in
turn on cccDNA formation or the maintenance of established cccDNA pools in chronically infected cells. To
increase the resolution of such studies, we will also examine at the single-cell level how the expression levels
of a given factor correlate with that of cccDNA. Altogether, these data will give us a far more comprehensive
view of this process critical to the persistence of HBV in chronically infected individuals.
项目摘要
慢性丙型肝炎病毒(HBV)感染每年导致887,000人死亡。治愈的核心挑战
HBV是病毒基因组的稳定闭合圆形DNA(CCCDNA)形式的稳定构造
取决于其一代的难以捉摸的宿主因素。使用酵母提取物屏幕,我们确定了五个核心
滞后链合成的成分 - PCNA,复制因子C(RFC)复合物,DNA聚合酶δ
(POLδ),FEN-1和DNA连接酶1(LIG1) - 对于CCCDNA的形成至关重要。我们重组了CCCDNA
具有纯化的人类同源物的形成,将其确定为必要的最小因素集
足以形成CCCDNA。我们进一步证明,抑制polδ会显着减少
CCCDNA形成。在此提案中,我们将基于这些发现,以确定
CCCDNA的形成,描绘了修复过程的每个步骤中每个因素的作用。在理解
rcDNA到CCCDNA修复的动力学,我们可以识别可能是新颖的潜在限制步骤
破坏CCCDNA形成和维护的治疗靶标。使用一系列创新技术
在细胞培养和鼠标模型系统中,我们将能够在物理相关的情况下测试我们的发现
可以加强数据影响的平台。发现对RC-到CCCDNA至关重要的因素
这些系统将通过Degron介导的方法中断转换,该方法将允许进行微调
控制表达以减轻任何潜在的细胞毒性。然后,我们可以监视每个因素的影响
打开CCCDNA形成或在慢性感染细胞中维持已建立的CCCDNA池。到
增加了此类研究的分辨率,我们还将在单细胞水平上检查表达水平如何
给定因子与CCCDNA的因子相关。总之,这些数据将使我们更加全面
这一过程对于长期感染的个体中HBV持续存在至关重要的观点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Ploss其他文献
Alexander Ploss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Ploss', 18)}}的其他基金
Mechanisms of hepatitis B virus cccDNA formation
乙型肝炎病毒cccDNA形成机制
- 批准号:
10393606 - 财政年份:2020
- 资助金额:
$ 55.41万 - 项目类别:
Mechanisms of hepatitis B virus cccDNA formation
乙型肝炎病毒cccDNA形成机制
- 批准号:
10610864 - 财政年份:2020
- 资助金额:
$ 55.41万 - 项目类别:
Mechanisms of hepatitis B virus cccDNA formation
乙型肝炎病毒cccDNA形成机制
- 批准号:
10032771 - 财政年份:2020
- 资助金额:
$ 55.41万 - 项目类别:
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
新型人源化小鼠 HBV-HIV 共感染的免疫损伤和发病机制建模
- 批准号:
10371657 - 财政年份:2018
- 资助金额:
$ 55.41万 - 项目类别:
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
新型人源化小鼠 HBV-HIV 共感染的免疫损伤和发病机制建模
- 批准号:
9981621 - 财政年份:2018
- 资助金额:
$ 55.41万 - 项目类别:
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
新型人源化小鼠 HBV-HIV 共感染的免疫损伤和发病机制建模
- 批准号:
10228671 - 财政年份:2018
- 资助金额:
$ 55.41万 - 项目类别:
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
新型人源化小鼠 HBV-HIV 共感染的免疫损伤和发病机制建模
- 批准号:
9789829 - 财政年份:2018
- 资助金额:
$ 55.41万 - 项目类别:
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
新型人源化小鼠 HBV-HIV 共感染的免疫损伤和发病机制建模
- 批准号:
10471797 - 财政年份:2018
- 资助金额:
$ 55.41万 - 项目类别:
Impact of species-specific host responses on restriction of hepatotropic viruses
物种特异性宿主反应对嗜肝病毒限制的影响
- 批准号:
9104080 - 财政年份:2015
- 资助金额:
$ 55.41万 - 项目类别:
Impact of species-specific host responses on restriction of hepatotropic viruses
物种特异性宿主反应对嗜肝病毒限制的影响
- 批准号:
8871022 - 财政年份:2015
- 资助金额:
$ 55.41万 - 项目类别:
相似国自然基金
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
- 批准号:81901635
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
IL-17促进系统性红斑狼疮发病中浆细胞功能的机制研究
- 批准号:81771761
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
中东呼吸综合征新型人源应急救治单克隆抗体保护作用机制研究
- 批准号:81772191
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
肺腺癌中Timp-1促癌机制的研究及其阻断抗体的运用
- 批准号:81672268
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
抗磷脂抗体诱导中性粒细胞释放NETs致抗磷脂综合征肾病的机制研究
- 批准号:81671589
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 55.41万 - 项目类别:
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
靶向 CCR6-CCL20 通路治疗银屑病关节和附着点炎症
- 批准号:
10699251 - 财政年份:2023
- 资助金额:
$ 55.41万 - 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
- 批准号:
10495114 - 财政年份:2023
- 资助金额:
$ 55.41万 - 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 55.41万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 55.41万 - 项目类别: